Focus groups identify support needs of patients who smoke
the ONA take:
A study by researchers from the UNC Department of Family Medicine and the Lineberger Comprehensive Cancer Center conducted a series of focus groups in which 33 participants—all current or recently quit smokers—shared their personal experiences with and ideas about smoking cessation. This study is one of the first efforts to explore the challenges smokers face.
The focus groups revealed that smokers want to know that their physicians understand the experience of being a smoker and treat them with respect.
They want their care to embrace the addition model. Not only do smokers want to talk about smoking at every visit, they are looking for specific advice, positive encouragement, and resources to help them with their smoking cessation efforts.
Focus group participants suggested outcomes measures that could improve cessation efforts. Suggested patient-centered measures included improved activity and energy levels, a sense of freedom in not having to plan around smoke breaks, and a sense of pride in achieving their goal of becoming smoke free.
The researchers hope the insight from their study will encourage health care providers to explore new patient-centered interventions, outcomes, and dissemination strategies to help smokers with their quit efforts.
Series of focus groups shared their personal experiences with and ideas about smoking cessation.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|